Ticker ctic
WebbCTi Biopharma Corp (ticker: CTIC) aktiesidan. Utdelning, ekonomi, aktiekurs och värdering av bolaget i visuellt format. iO Charts. Ticker CTIC. Price 5.63. Stock movement down-0.07 (-1.23 %) Company name CTi Biopharma Corp Exchange (NASDAQ, Currency USD) Sector. Healthcare > Biotechnology. Marknadsvärde 613.48M Ent-värde 675.93M. Pris ... WebbSee New Opinions/Signals for ALL Tickers. Statistics from all past Buy/Sell opinions in Tudal. Total ... Click to see the forecast history of all tickers. CTIC : CTI BioPharma stock forecast, predictions, and share price target for 2024, 2024 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by ...
Ticker ctic
Did you know?
WebbCti Biopharma stock was originally listed at a price of $203,160.00 in Dec 31, 1997. If you had invested in Cti Biopharma stock at $203,160.00, your return over the last 25 years would have been -100%, for an annualized return of -35.04% (not including any dividends or dividend reinvestments).
WebbCti Biopharma stock was originally listed at a price of $203,160.00 in Dec 31, 1997. If you had invested in Cti Biopharma stock at $203,160.00, your return over the last 25 years … Webb29 mars 2024 · Stocks & ETFs, MFs, Crypto & FOREX. AI Pattern Search Engine. Stocks & ETFs, Crypto & FOREX
WebbCTIC has around 2.3M shares in the U.S. ETF market. The largest ETF holder of CTIC is the Invesco DWA Healthcare Momentum ETF (PTH), with approximately 1.36M shares. Webb13 apr. 2024 · Ticker Symbol CTIC Full Company Profile Financial Performance Financial Statements Analyst Forecast According to 15 analysts, the average rating for CTIC stock …
Webb11 aug. 2024 · TICKERS: CTIC. Coverage Initiated on Developer of Treatment for Myelofibrosis, GvHD, COVID-19 ... (CTIC:NASDAQ), a developer of therapeutics for blood-related cancers, with a Buy rating and a $7 per share target price. In comparison, the current share price is about $2.80.
WebbCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related … b2幽灵壁纸WebbInvesting.com - CTi Biopharma (NASDAQ: CTIC) reported first quarter EPS of $-0.140, $0.04 worse than the analyst estimate of $-0.097. Revenue for the quarter came in at … tauranga honda motorcyclesWebbAccording to 3 Wall Street analyst s that have issued a 1 year CTIC price target, the average CTIC price target is $10.33, with the highest CTIC stock price forecast at $13.00 and the … tauranga hospital departmentsWebb6 mars 2024 · SEATTLE, Mar. 31, 2024 - CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended December 31, 2024. “VONJO’s recent FDA approval establishes a new standard of care for myelofibrosis patients suffering from cytopenic myelofibrosis. tauranga hospital email addressWebbCTI BioPharma Corp. (NASDAQ:CTIC) Q4 2024 Earnings Call Transcript March 6, 2024 Operator: Good morning, and welcome to the CTI BioPharma Fourth Quarter and Year … View the basic CTIC option chain and compare options of CTI BioPharma Corp. … Get the detailed quarterly/annual income statement for CTI BioPharma Corp. … CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company … Research Reports - CTI BioPharma Corp. (CTIC) - Yahoo Finance Find out the direct holders, institutional holders and mutual fund holders for CTI … See CTI BioPharma Corp. (CTIC) stock analyst estimates, including earnings and … See the company profile for CTI BioPharma Corp. (CTIC) including business … CTI BioPharma to Participate in Two Upcoming Investor Conferences in April … tauranga hospital mental healthWebb17 mars 2024 · CTI BioPharma Corp. analyst estimates, including CTIC earnings per share estimates and analyst recommendations. tauranga hospital midwivesWebbCTIC Analysis - $CTIC PRICE TARGETS & STOCK BREAKDOWN - YouTube. CTIC Analysis - $CTIC PRICE TARGETS & STOCK BREAKDOWNStock Tickers: #CTIC b2正版主题